News

Danish pharmaceutical giant Novo Nordisk on Tuesday said it has followed “smart Indian pricing,” which is lower than prices in many countries, to make its blockbuster weight-loss drug Wegovy ...
Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) both jumped 0 ...
The Sarajevo International Airport announced that they are still among the top five airports in Europe in terms of passenger traffic growth. Referring to data from the Airports Council International ...
CagriSema shows mild-to-moderate side effects in trials Researcher sees benefit to additional weight-loss options Novo Nordisk plans regulatory filing for CagriSema in early 2026 June 22 (Reuters ...
The three-day fair event “Halal Expo Sarajevo 2025” today brought together exhibitors from more than 20 countries in the capital of Bosnia and Herzegovina, including leading companies, investors and ...
France’s BPCE has agreed a 6.4 billion euros ($7.39 billion) deal to acquire Portugal's Novo Banco, including a 75% stake held by U.S. private equity firm Lone Star, BPCE and Lone Star said on ...
The Swissotel in Sarajevo, Bosnia. (Google Maps) JTA — A meeting of leading European rabbis has been canceled in Sarajevo after high-profile appeals against their gathering.
In January, Novo recorded 22% weight loss in people who received weekly amycretin injections for 36 weeks in a phase 1b/2a study. The company didn’t mention whether weight loss appeared to ...
The semi-closed session on the hushed campus of the International University of Sarajevo was the Gaza Tribunal’s first meeting, with the final verdict planned for a last session in October. The ...
Novo has agreed to pay up to $812 million, including an upfront payment, research costs and milestones, for a global license to small molecules aimed at a GPCR target that isn’t an incretin. GLP ...
Deep Apple discovers drug candidates using its AI-based platform that screens virtual libraries of billions of compounds to cut drug discovery time, the company said. Under the deal, Novo will ...